MED28
Basic information
Region (hg38): 4:17614641-17634105
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MED28 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 19 | 19 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 13 | 13 | ||||
Total | 0 | 0 | 33 | 0 | 0 |
Variants in MED28
This is a list of pathogenic ClinVar variants found in the MED28 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-17614659-C-A | not specified | Uncertain significance (Dec 20, 2023) | ||
4-17614671-G-C | not specified | Uncertain significance (Oct 21, 2021) | ||
4-17614671-G-T | not specified | Uncertain significance (Dec 20, 2023) | ||
4-17614673-G-A | Focal segmental glomerulosclerosis | Uncertain significance (Nov 13, 2019) | ||
4-17614673-G-T | not specified | Uncertain significance (Dec 06, 2021) | ||
4-17614686-G-A | not specified | Uncertain significance (Oct 27, 2023) | ||
4-17614703-C-T | not specified | Uncertain significance (Nov 09, 2023) | ||
4-17614704-C-T | not specified | Uncertain significance (Aug 08, 2022) | ||
4-17614706-C-T | Hereditary breast ovarian cancer syndrome | Uncertain significance (Aug 01, 2020) | ||
4-17614716-C-G | not specified | Uncertain significance (Mar 12, 2024) | ||
4-17614725-C-G | not specified | Uncertain significance (Jan 09, 2024) | ||
4-17614791-A-G | not specified | Uncertain significance (Oct 29, 2021) | ||
4-17621601-A-G | not specified | Uncertain significance (Oct 02, 2023) | ||
4-17621602-T-C | not specified | Uncertain significance (Mar 08, 2024) | ||
4-17621613-C-G | not specified | Uncertain significance (Aug 02, 2023) | ||
4-17621638-G-A | not specified | Uncertain significance (Aug 21, 2023) | ||
4-17621689-T-G | not specified | Uncertain significance (Feb 27, 2024) | ||
4-17623613-C-G | not specified | Uncertain significance (Feb 12, 2024) | ||
4-17623710-A-C | not specified | Uncertain significance (Dec 14, 2022) | ||
4-17623721-G-A | not specified | Uncertain significance (Jun 17, 2024) | ||
4-17623758-A-G | not specified | Uncertain significance (Mar 02, 2023) | ||
4-17632593-T-G | not specified | Uncertain significance (Dec 17, 2023) | ||
4-17633740-C-T | not specified | Uncertain significance (Jul 20, 2022) | ||
4-17633777-T-C | not specified | Uncertain significance (Nov 15, 2021) | ||
4-17633788-T-C | not specified | Uncertain significance (Nov 09, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MED28 | protein_coding | protein_coding | ENST00000237380 | 4 | 19475 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000111 | 0.614 | 125724 | 0 | 23 | 125747 | 0.0000915 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.279 | 106 | 98.2 | 1.08 | 0.00000491 | 1144 |
Missense in Polyphen | 16 | 16.485 | 0.97055 | 233 | ||
Synonymous | -2.48 | 62 | 41.6 | 1.49 | 0.00000227 | 355 |
Loss of Function | 0.717 | 7 | 9.37 | 0.747 | 4.65e-7 | 101 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000215 | 0.000212 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000803 | 0.0000791 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000199 | 0.000196 |
Other | 0.000330 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. May be part of a complex containing NF2/merlin that participates in cellular signaling to the actin cytoskeleton downstream of tyrosine kinase signaling pathways. {ECO:0000269|PubMed:15467741}.;
- Pathway
- Developmental Biology;Transcriptional regulation of white adipocyte differentiation
(Consensus)
Recessive Scores
- pRec
- 0.166
Intolerance Scores
- loftool
- 0.377
- rvis_EVS
- -0.05
- rvis_percentile_EVS
- 49.76
Haploinsufficiency Scores
- pHI
- 0.125
- hipred
- Y
- hipred_score
- 0.719
- ghis
- 0.645
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.991
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Med28
- Phenotype
- cellular phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; hearing/vestibular/ear phenotype;
Gene ontology
- Biological process
- stem cell population maintenance;negative regulation of smooth muscle cell differentiation
- Cellular component
- nucleoplasm;membrane;mediator complex;cortical actin cytoskeleton
- Molecular function
- actin binding;protein binding